"10.1371_journal.pone.0081126","plos one","2014-01-03T00:00:00Z","Malathi Banda; Cecilia L Speyer; Sara N Semma; Kingsley O Osuala; Nicole Kounalakis; Keila E Torres Torres; Nicola J Barnard; Hyunjin J Kim; Bonnie F Sloane; Fred R Miller; James S Goydos; David H Gorski","Department of Surgery, Wayne State University School of Medicine, Detroit, Michigan, United States of America; Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America; Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan, United States of America; Division of Surgical Oncology, UMDNJ-Robert Wood Johnson University Medical School, New Brunswick, New Jersey, United States of America; Department of Pathology, UMDNJ-Robert Wood Johnson University Medical School, New Brunswick, New Jersey, United States of America; The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, United States of America","Conceived and designed the experiments: DHG MB CLS JSG BFS. Performed the experiments: MB CLS SNS KOO NK KETT NJB HJK. Analyzed the data: MB DHG FRM CLS BFS KOO. Contributed reagents/materials/analysis tools: JSG FRM. Wrote the paper: DHG MB CLS JSG.","The corresponding author (DHG) was the recipient of a pilot grant from Bayer Healthcare to study inhibition of glutamatergic signaling as a therapeutic target in various cancers. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Malathi Banda","MB",12,TRUE,5,8,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
